Because of an interest in developing new approaches for the treatment of bleeding disorders [13–16], and to analyze the potential role of FX in pathophysiological processes such as sepsis and metastasis [17,18], we wished to develop a viable murine model of severe FX deficiency. The gene discussed is F10; the disease is Sepsis.